ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Internal Medicine

Top Internal Medicine Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KHALID WASEEM MD

Internal Medicine

26,984

$1.45M

674
463 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $69

SHOAIB HASHMI MD

Internal Medicine

25,491

$1.47M

537
412 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $69

SUNIL GUPTA MD

Internal Medicine

25,060

$1.09M

745
644 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $69

HARJIT SIDHU M.D.

Internal Medicine

21,774

$986K

463
413 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $69

TASNEEM LAKHANI MD

Internal Medicine

21,520

$1.29M

424
357 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $69

ROBUSTIANO BARRERA M.D.

Internal Medicine

20,833

$998K

614
527 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $69

VEL NATESAN M.D.

Internal Medicine

20,827

$1.46M

1165
1008 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

3%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$70
Average prescription price

Avg: $69

RAVI PASSI MD

Internal Medicine

20,711

$1.13M

545
466 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $69

ALEXANDER POKOV MD

Internal Medicine

20,536

$1.4M

406
387 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $69

NARENDER BHARAJ M.D.

Internal Medicine

20,380

$1.21M

637
487 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $69

DAVID DUNN M.D.

Internal Medicine

20,341

$1.19M

833
771 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $69

FELIX SOKOLSKY MD

Internal Medicine

20,162

$1.13M

523
500 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $69

TARIQ MAHMOOD MD

Internal Medicine

19,859

$907K

474
422 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $69

JEFFREY ZIBELL MD

Internal Medicine

19,637

$1.11M

493
454 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

3%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $69

HI SIM M.D.

Internal Medicine

19,392

$1.06M

553
467 are 65+

24%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $69

MAHESH MOONDRA M.D.

Internal Medicine

19,320

$1.08M

607
515 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $69

SHIV KHANNA MD

Internal Medicine

18,703

$1.1M

636
543 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $69

ANIL UBEROI M.D.

Internal Medicine

17,895

$1.06M

572
320 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $69

ANDREW LAZRIS MD

Internal Medicine

17,631

$828K

524
500 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $69

ELLIOTT GORBATY M.D.

Internal Medicine

17,438

$954K

497
421 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $69

WONSOCK SHIN M.D.

Internal Medicine

16,743

$883K

534
478 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $69

ROBERT KROOPNICK M.D.

Internal Medicine

15,871

$1.03M

671
462 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $69

YEONG OH MD

Internal Medicine

15,457

$1.4M

609
579 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

3%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 26%

$90
Average prescription price

Avg: $69

VINU GANTI MD

Internal Medicine

15,079

$1.2M

538
403 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$80
Average prescription price

Avg: $69

SHAWN DHILLON M.D.

Internal Medicine

15,058

$1.03M

735
464 are 65+

26%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $69

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank